Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 961 to 962 of 962 entries
Sorted by: Best Match Show Resources per page
Estimating the impact of interventions against COVID-19: From lockdown to vaccination.

PloS one

Thompson J, Wattam S.
PMID: 34919576
PLoS One. 2021 Dec 17;16(12):e0261330. doi: 10.1371/journal.pone.0261330. eCollection 2021.

Coronavirus disease 2019 (COVID-19) is an infectious disease of humans caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the first case was identified in China in December 2019 the disease has spread worldwide, leading to an ongoing...

Cite
Thompson J, Wattam S. Estimating the impact of interventions against COVID-19: From lockdown to vaccination. PLoS One. 2021;16(12):e0261330doi: 10.1371/journal.pone.0261330.
Thompson, J., & Wattam, S. (2021). Estimating the impact of interventions against COVID-19: From lockdown to vaccination. PloS one, 16(12), e0261330. https://doi.org/10.1371/journal.pone.0261330
Thompson, James, and Wattam, Stephen. "Estimating the impact of interventions against COVID-19: From lockdown to vaccination." PloS one vol. 16,12 (2021): e0261330. doi: https://doi.org/10.1371/journal.pone.0261330
Thompson J, Wattam S. Estimating the impact of interventions against COVID-19: From lockdown to vaccination. PLoS One. 2021 Dec 17;16(12):e0261330. doi: 10.1371/journal.pone.0261330. eCollection 2021. PMID: 34919576.
Copy Download .nbib Format: NLM
Validation of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy.

The Journal of molecular diagnostics : JMD

Stence AA, Thomason JG, Pruessner JA, Sompallae RR, Snow AN, Ma D, Moore SA, Bossler AD.
PMID: 34384893
J Mol Diagn. 2021 Nov;23(11):1506-1514. doi: 10.1016/j.jmoldx.2021.07.021. Epub 2021 Aug 09.

The molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD) relies on detecting contractions of the unique D4Z4 repeat array at the chromosome 4q35 locus in the presence of a permissive 4q35A haplotype. Long, intact DNA molecules are required for accurate...

Cite
Stence AA, Thomason JG, Pruessner JA, et al. Validation of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy. J Mol Diagn. 2021;23(11):1506-1514doi: 10.1016/j.jmoldx.2021.07.021.
Stence, A. A., Thomason, J. G., Pruessner, J. A., Sompallae, R. R., Snow, A. N., Ma, D., Moore, S. A., & Bossler, A. D. (2021). Validation of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy. The Journal of molecular diagnostics : JMD, 23(11), 1506-1514. https://doi.org/10.1016/j.jmoldx.2021.07.021
Stence, Aaron A, et al. "Validation of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy." The Journal of molecular diagnostics : JMD vol. 23,11 (2021): 1506-1514. doi: https://doi.org/10.1016/j.jmoldx.2021.07.021
Stence AA, Thomason JG, Pruessner JA, Sompallae RR, Snow AN, Ma D, Moore SA, Bossler AD. Validation of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy. J Mol Diagn. 2021 Nov;23(11):1506-1514. doi: 10.1016/j.jmoldx.2021.07.021. Epub 2021 Aug 09. PMID: 34384893.
Copy Download .nbib Format: NLM
Showing 961 to 962 of 962 entries